Sandra Close, PhD
Chief Operations Officer, Chief Compliance Officer
Sandra Close is the Chief Operations Officer and Chief Compliance Officer of Foresight Diagnostics. Sandra has extensive experience in delivering drugs and diagnostics to market, with a focus on organizational structure, business strategy, and quality and regulatory requirements. Prior to joining Foresight, she served as Chief Diagnostic Strategy Officer at ArcherDX/Invitae, where she led efforts to advance an NGS-based molecular diagnostic platform for genetic mutation detection, including minimal residual disease (MRD) products. Sandra also served as Chief of Integrative Science and Collaborative Research for BioStatistics Solutions, Inc., Chief Scientific Officer at Arrogen, and Research Advisor at Eli Lilly and Company. Sandra received her PhD in medical and molecular genetics from Indiana University-Indianapolis, MS from Columbia University in New York City, and BS from Indiana University-Bloomington.
